References:

<HIDE>

[1]Agrawal, N., Banerjee, R., 2008. Human polycomb 2 protein is a SUMO E3 ligase and alleviates substrate-induced inhibition of cystathionine β-synthase sumoylation. PLoS ONE, 3(12):e4032.

[2]Aloia, L., Di Stefano, B., Di Croce, L., 2013. Polycomb complexes in stem cells and embryonic development. Development, 140(12):2525-2534.

[3]Atchison, L., Ghias, A., Wilkinson, F., et al., 2003. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J., 22(6):1347-1358.

[4]Basu, A., Wilkinson, F.H., Colavita, K., et al., 2014. YY1 DNA binding and interaction with YAF2 is essential for polycomb recruitment. Nucl. Acids Res., 42(4):2208-2223.

[5]Baumann, C., de la Fuente, R., 2011. Role of polycomb group protein Cbx2/M33 in meiosis onset and maintenance of chromosome stability in the mammalian germline. Genes, 2(1):59-80.

[6]Bengani, H., Mendiratta, S., Maini, J., et al., 2013. Identification and validation of a putative polycomb responsive element in the human genome. PLoS ONE, 8(6):e67217.

[7]Bernard, D., Martinez-Leal, J.F., Rizzo, S., et al., 2005. CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene, 24(36):5543-5551.

[8]Bernstein, B.E., Mikkelsen, T.S., Xie, X., et al., 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell, 125(2):315-326.

[9]Bernstein, E., Duncan, E.M., Masui, O., et al., 2006. Mouse polycomb proteins bind differentially to methylated histone H3 and RNA and are enriched in facultative heterochromatin. Mol. Cell. Biol., 26(7):2560-2569.

[10]Bezsonova, I., Walker, J.R., Bacik, J.P., et al., 2009. Ring1B contains a ubiquitin-like docking module for interaction with Cbx proteins. Biochemistry, 48(44):10542-10548.

[11]Biason-Lauber, A., Konrad, D., Meyer, M., et al., 2009. Ovaries and female phenotype in a girl with 46, XY karyotype and mutations in the CBX2 gene. Am. J. Hum. Genet., 84(5):658-663.

[12]Brockdorff, N., 2013. Noncoding RNA and polycomb recruitment. RNA, 19(4):429-442.

[13]Brookes, E., de Santiago, I., Hebenstreit, D., et al., 2012. Polycomb associates genome-wide with a specific RNA polymerase II variant, and regulates metabolic genes in ESCs. Cell Stem Cell, 10(2):157-170.

[14]Brown, J.L., Kassis, J.A., 2013. Architectural and functional diversity of polycomb group response elements in Drosophila. Genetics, 195(2):407-419.

[15]Buchwald, G., van der Stoop, P., Weichenrieder, O., et al., 2006. Structure and E3-ligase activity of the ring-ring complex of polycomb proteins Bmi1 and Ring1b. EMBO J., 25(11):2465-2474.

[16]Buschbeck, M., Uribesalgo, I., Wibowo, I., et al., 2009. The histone variant macroH2A is an epigenetic regulator of key developmental genes. Nat. Struct. Mol. Biol., 16(10):1074-1079.

[17]Cantin, G.T., Yi, W., Lu, B., et al., 2008. Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J. Proteome Res., 7(3):1346-1351.

[18]Chen, R.Q., Yang, Q.K., Lu, B.W., et al., 2009. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res., 69(6):2663-2668.

[19]Coré, N., Bel, S., Gaunt, S.J., et al., 1997. Altered cellular proliferation and mesoderm patterning in polycomb-M33-deficient mice. Development, 124(3):721-729.

[20]Coré, N., Joly, F., Boned, A., et al., 2004. Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice. Oncogene, 23(46):7660-7668.

[21]Crea, F., Paolicchi, E., Marquez, V.E., et al., 2012. Polycomb genes and cancer: time for clinical application? Crit. Rev. Oncol. Hematol., 83(2):184-193.

[22]Creyghton, M.P., Markoulaki, S., Levine, S.S., et al., 2008. H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell, 135(4):649-661.

[23]Daub, H., Olsen, J.V., Bairlein, M., et al., 2008. Kinase-selective enrichment enables quantitative phospho-proteomics of the kinome across the cell cycle. Mol. Cell, 31(3):438-448.

[24]Dephoure, N., Zhou, C., Villen, J., et al., 2008. A quantitative atlas of mitotic phosphorylation. PNAS, 105(31):10762-10767.

[25]Dietrich, N., Bracken, A.P., Trinh, E., et al., 2007. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J., 26(6):1637-1648.

[26]Dou, H., Huang, C., van Nguyen, T., et al., 2011. SUMOylation and de-SUMOylation in response to DNA damage. FEBS Lett., 585(18):2891-2896.

[27]Forzati, F., Federico, A., Pallante, P., et al., 2012a. CBX7 is a tumor suppressor in mice and humans. J. Clin. Invest., 122(2):612-623.

[28]Forzati, F., Federico, A., Pallante, P., et al., 2012b. Tumor suppressor activity of CBX7 in lung carcinogenesis. Cell Cycle, 11(10):1888-1891.

[29]Galanty, Y., Belotserkovskaya, R., Coates, J., et al., 2009. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature, 462(7275):935-939.

[30]Gao, Z., Zhang, J., Bonasio, R., et al., 2012. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell, 45(3):344-356.

[31]Gil, J., Bernard, D., Martinez, D., et al., 2004. Polycomb CBX7 has a unifying role in cellular lifespan. Nat. Cell Biol., 6(1):67-72.

[32]Hannafon, B.N., Sebastiani, P., de las Morenas, et al., 2011. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res., 13(2):R24.

[33]Hatano, A., Matsumoto, M., Higashinakagawa, T., et al., 2010. Phosphorylation of the chromodomain changes the binding specificity of Cbx2 for methylated histone H3. Biochem. Biophys. Res. Commun., 397(1):93-99.

[34]Hinz, S., Kempkensteffen, C., Christoph, F., et al., 2008. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Tumour Biol., 29(5):323-329.

[35]Ismail, I.H., Gagne, J.P., Caron, M.C., et al., 2012. CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. Nucl. Acids Res., 40(12):5497-5510.

[36]Kagey, M.H., Melhuish, T.A., Wotton, D., 2003. The polycomb protein Pc2 is a SUMO E3. Cell, 113(1):127-137.

[37]Kang, X., Qi, Y., Zuo, Y., et al., 2010. SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol. Cell, 38(2):191-201.

[38]Kanhere, A., Viiri, K., Araujo, C.C., et al., 2010. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol. Cell, 38(5):675-688.

[39]Karamitopoulou, E., Pallante, P., Zlobec, I., et al., 2010. Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer. Eur. J. Cancer, 46(8):1438-1444.

[40]Katoh-Fukui, Y., Tsuchiya, R., Shiroishi, T., et al., 1998. Male-to-female sex reversal in M33 mutant mice. Nature, 393(6686):688-692.

[41]Katoh-Fukui, Y., Owaki, A., Toyama, Y., et al., 2005. Mouse polycomb M33 is required for splenic vascular and adrenal gland formation through regulating Ad4BP/SF1 expression. Blood, 106(5):1612-1620.

[42]Katoh-Fukui, Y., Miyabayashi, K., Komatsu, T., et al., 2012. Cbx2, a polycomb group gene, is required for Sry gene expression in mice. Endocrinology, 153(2):913-924.

[43]Klauke, K., Radulovic, V., Broekhuis, M., et al., 2013. Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation. Nat. Cell Biol., 15(4):353-362.

[44]Kotake, Y., Nakagawa, T., Kitagawa, K., et al., 2011. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15^INK4B tumor suppressor gene. Oncogene, 30(16):1956-1962.

[45]Ku, M., Koche, R.P., Rheinbay, E., et al., 2008. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet., 4(10):e1000242.

[46]Lee, S.H., Um, S.J., Kim, E.J., 2013. CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1. Cancer Lett., 335(2):397-403.

[47]Lee, S.W., Lee, M.H., Park, J.H., et al., 2012. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage. EMBO J., 31(23):4441-4452.

[48]Lewis, E.B., 1978. A gene complex controlling segmentation in Drosophila. Nature, 276(5688):565-570.

[49]Li, B., Zhou, J., Liu, P., et al., 2007. Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem. J., 405(2):369-378.

[50]Li, G., Warden, C., Zou, Z., et al., 2013. Altered expression of polycomb group genes in glioblastoma multiforme. PLoS ONE, 8(11):e80970.

[51]Liu, B., Liu, Y.F., Du, Y.R., et al., 2013. Cbx4 regulates the proliferation of thymic epithelial cells and thymus function. Development, 140(4):780-788.

[52]Long, J., Zuo, D., Park, M., 2005. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J. Biol. Chem., 280(42):35477-35489.

[53]Luis, N.M., Morey, L., Mejetta, S., et al., 2011. Regulation of human epidermal stem cell proliferation and senescence requires polycomb-dependent and -independent functions of Cbx4. Cell Stem Cell, 9(3):233-246.

[54]MacPherson, M.J., Beatty, L.G., Zhou, W., et al., 2009. The CTCF insulator protein is posttranslationally modified by SUMO. Mol. Cell. Biol., 29(3):714-725.

[55]Maertens, G.N., El Messaoudi-Aubert, S., Racek, T., et al., 2009. Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. PLoS ONE, 4(7):e6380.

[56]Maethner, E., Garcia-Cuellar, M.P., Breitinger, C., et al., 2013. MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells. Cell Rep., 3(5):1553-1566.

[57]Malik, B., Hemenway, C.S., 2013. CBX8, a component of the polycomb PRC1 complex, modulates DOT1L-mediated gene expression through AF9/MLLT3. FEBS Lett., 587(18):3038-3044.

[58]Margueron, R., Li, G., Sarma, K., et al., 2008. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell, 32(4):503-518.

[59]Margueron, R., Justin, N., Ohno, K., et al., 2009. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature, 461(7265):762-767.

[60]Mendenhall, E.M., Koche, R.P., Truong, T., et al., 2010. GC-rich sequence elements recruit PRC2 in mammalian ES cells. PLoS Genet., 6(12):e1001244.

[61]Merrill, J.C., Kagey, M.H., Melhuish, T.A., et al., 2010. Inhibition of CtBP1 activity by Akt-mediated phosphorylation. J. Mol. Biol., 398(5):657-671.

[62]Mills, A.A., 2010. Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat. Rev. Cancer, 10(10):669-682.

[63]Mohammad, H.P., Cai, Y., McGarvey, K.M., et al., 2009. Polycomb CBX7 promotes initiation of heritable repression of genes frequently silenced with cancer-specific DNA hypermethylation. Cancer Res., 69(15):6322-6330.

[64]Morey, L., Helin, K., 2010. Polycomb group protein-mediated repression of transcription. Trends Biochem. Sci., 35(6):323-332.

[65]Morey, L., Pascual, G., Cozzuto, L., et al., 2012. Non-overlapping functions of the polycomb group Cbx family of proteins in embryonic stem cells. Cell Stem Cell, 10(1):47-62.

[66]Morris, J.R., Boutell, C., Keppler, M., et al., 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature, 462(7275):886-890.

[67]Muller, J., Verrijzer, P., 2009. Biochemical mechanisms of gene regulation by polycomb group protein complexes. Curr. Opin. Genet. Dev., 19(2):150-158.

[68]Muller, J., Gaunt, S., Lawrence, P.A., 1995. Function of the polycomb protein is conserved in mice and flies. Development, 121(9):2847-2852.

[69]Nacerddine, K., Lehembre, F., Bhaumik, M., et al., 2005. The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell, 9(6):769-779.

[70]O'Loghlen, A., Munoz-Cabello, A.M., Gaspar-Maia, A., et al., 2012. MicroRNA regulation of Cbx7 mediates a switch of polycomb orthologs during ESC differentiation. Cell Stem Cell, 10(1):33-46.

[71]Oh, Y., Chung, K.C., 2012. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling. J. Biol. Chem., 287(21):17517-17529.

[72]Oh, Y., Kim, Y.M., Mouradian, M.M., et al., 2011. Human polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation. Brain Res., 1381:78-89.

[73]Oktaba, K., Gutierrez, L., Gagneur, J., et al., 2008. Dynamic regulation by polycomb group protein complexes controls pattern formation and the cell cycle in Drosophila. Dev. Cell, 15(6):877-889.

[74]Olsen, J.V., Blagoev, B., Gnad, F., et al., 2006. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell, 127(3):635-648.

[75]Pallante, P., Federico, A., Berlingieri, M.T., et al., 2008. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res., 68(16):6770-6778.

[76]Pallante, P., Terracciano, L., Carafa, V., et al., 2010. The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. Eur. J. Cancer, 46(12):2304-2313.

[77]Pasini, D., Bracken, A.P., Jensen, M.R., et al., 2004. Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity. EMBO J., 23(20):4061-4071.

[78]Pelisch, F., Pozzi, B., Risso, G., et al., 2012. DNA damage-induced heterogeneous nuclear ribonucleoprotein K sumoylation regulates p53 transcriptional activation. J. Biol. Chem., 287(36):30789-30799.

[79]Pemberton, H., Anderton, E., Patel, H., et al., 2014. Genome-wide co-localization of polycomb orthologs and their effects on gene expression in human fibroblasts. Genome Biol., 15(2):R23.

[80]Plath, K., Fang, J., Mlynarczyk-Evans, S.K., et al., 2003. Role of histone H3 lysine 27 methylation in X inactivation. Science, 300(5616):131-135.

[81]Ren, X., Kerppola, T.K., 2011. REST interacts with Cbx proteins and regulates polycomb repressive complex 1 occupancy at RE1 elements. Mol. Cell. Biol., 31(10):2100-2110.

[82]Ren, X., Vincenz, C., Kerppola, T.K., 2008. Changes in the distributions and dynamics of polycomb repressive complexes during embryonic stem cell differentiation. Mol. Cell. Biol., 28(9):2884-2895.

[83]Richly, H., Aloia, L., di Croce, L., 2011. Roles of the polycomb group proteins in stem cells and cancer. Cell Death Dis., 2(9):e204.

[84]Rikova, K., Guo, A., Zeng, Q., et al., 2007. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell, 131(6):1190-1203.

[85]Roscic, A., Moller, A., Calzado, M.A., et al., 2006. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol. Cell, 24(1):77-89.

[86]Schorderet, P., Duboule, D., 2011. Structural and functional differences in the long non-coding RNA hotair in mouse and human. PLoS Genet., 7(5):e1002071.

[87]Schorderet, P., Lonfat, N., Darbellay, F., et al., 2013. A genetic approach to the recruitment of PRC2 at the HoxD locus. PLoS Genet., 9(11):e1003951.

[88]Schwartz, Y.B., Pirrotta, V., 2013. A new world of polycombs: unexpected partnerships and emerging functions. Nat. Rev. Genet., 14(12):853-864.

[89]Scott, C.L., Gil, J., Hernando, E., et al., 2007. Role of the chromobox protein CBX7 in lymphomagenesis. PNAS, 104(13):5389-5394.

[90]Senthilkumar, R., Mishra, R.K., 2009. Novel motifs distinguish multiple homologues of polycomb in vertebrates: expansion and diversification of the epigenetic toolkit. BMC Genom., 10:549.

[91]Shinjo, K., Yamashita, Y., Yamamoto, E., et al., 2013. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int. J. Cancer, in press.

[92]Simon, J., Chiang, A., Bender, W., et al., 1993. Elements of the Drosophila bithorax complex that mediate repression by polycomb group products. Dev. Biol., 158(1):131-144.

[93]Simon, J.A., Kingston, R.E., 2013. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol. Cell, 49(5):808-824.

[94]Song, J., Durrin, L.K., Wilkinson, T.A., et al., 2004. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. PNAS, 101(40):14373-14378.

[95]Srinivasan, L., Atchison, M.L., 2004. YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev., 18(21):2596-2601.

[96]Struhl, G., 1981. A gene product required for correct initiation of segmental determination in Drosophila. Nature, 293(5827):36-41.

[97]Tan, J., Jones, M., Koseki, H., et al., 2011. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell, 20(5):563-575.

[98]Tavares, L., Dimitrova, E., Oxley, D., et al., 2012. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me³. Cell, 148(4):664-678.

[99]Tsai, M.C., Manor, O., Wan, Y., et al., 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 329(5992):689-693.

[100]van den Boom, V., Rozenveld-Geugien, M., Bonardi, F., et al., 2013. Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells. Blood, 121(13):2452-2461.

[101]Vincenz, C., Kerppola, T.K., 2008. Different polycomb group CBX family proteins associate with distinct regions of chromatin using nonhomologous protein sequences. PNAS, 105(43):16572-16577.

[102]Wang, B., Tang, J., Liao, D., et al., 2013. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann. Surg. Oncol., 20(S3):S684-S692.

[103]Wang, H., Wang, L., Erdjument-Bromage, H., et al., 2004. Role of histone H2A ubiquitination in polycomb silencing. Nature, 431(7010):873-878.

[104]Woo, C.J., Kharchenko, P.V., Daheron, L., et al., 2010. A region of the human HOXD cluster that confers polycomb-group responsiveness. Cell, 140(1):99-110.

[105]Woo, C.J., Kharchenko, P.V., Daheron, L., et al., 2013. Variable requirements for DNA-binding proteins at polycomb-dependent repressive regions in human HOX clusters. Mol. Cell. Biol., 33(16):3274-3285.

[106]Wotton, D., Merrill, J.C., 2007. Pc2 and SUMOylation. Biochem. Soc. Trans., 35(Pt 6):1401-1404.

[107]Wu, H.A., Balsbaugh, J.L., Chandler, H., et al., 2013. Mitogen-activated protein kinase signaling mediates phosphorylation of polycomb ortholog Cbx7. J. Biol. Chem., 288(51):36398-36408.

[108]Wu, X., Johansen, J.V., Helin, K., 2013. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation. Mol. Cell, 49(6):1134-1146.

[109]Yang, L., Lin, C., Liu, W., et al., 2011. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell, 147(4):773-788.

[110]Yap, K.L., Li, S., Munoz-Cabello, A.M., et al., 2010. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol. Cell, 38(5):662-674.

[111]Zhang, X.W., Zhang, L., Qin, W., et al., 2010. Oncogenic role of the chromobox protein CBX7 in gastric cancer. J. Exp. Clin. Cancer Res., 29(1):114.

[112]Zhao, J., Sun, B.K., Erwin, J.A., et al., 2008. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science, 322(5902):750-756.

[113]Zhao, J., Ohsumi, T.K., Kung, J.T., et al., 2010. Genome-wide identification of polycomb-associated RNAs by RIP-seq. Mol. Cell, 40(6):939-953.

[114]Zhou, X., Zhang, H.L., Gu, G.F., et al., 2013. Investigation of the relationship between chromobox homolog 8 and nucleus pulposus cells degeneration in rat intervertebral disc. In Vitro Cell. Dev. Biol. Anim., 49(4):279-286.